Abstract:Synthetic receptors control cell behavior in response to environmental stimuli for applications in basic research and cell therapy. However, the integration of synthetic receptors in unexplored contexts is cumbersome, especially for nonspecialist laboratories. Here, I provide a detailed protocol on how to use receptors of the generalized extracellular molecule sensor (GEMS) platform. GEMS is a modular receptor system that can be adapted to sense molecules of choice by using affinity domains that dimerize in response to the target. GEMS consist of an erythropoietin receptor scaffold that has been mutated to no longer bind to erythropoietin. N-terminal fusions with affinity domains, such as single chain variable fragments (scFvs), that bind to two epitopes on the same target activate the receptor. The intracellular receptor domain can be chosen from several signal transduction domains of single-pass transmembrane receptors to activate endogenous signaling pathways. As of now, GEMS have been used for sensing prostate specific antigen (PSA), the synthetic azo dye RR120, caffeine, nicotine, rapamycin, the SunTag peptide, and a de novo designed protein displaying two viral epitopes. The tested intracellular domains were derived from FGFR1, IL-6RB, and VEGFR2, and were used to drive transgene expression from reporter plasmids responsive to the endogenous transcription factors STAT3, NFAT, NF-κB, and a synthetic transcription factor activated by the MAPK pathway. In this protocol, I focus on transient transfections of HEK293T cells and include several general notes about cell handling. While the described methods are optimized for experiments with GEMS, most of the described techniques are general procedures to set up synthetic biology experiments in mammalian cell culture. I outline how to generate stable cell lines and share tips on how to adapt GEMS for new ligands. The main objective of this protocol is to make the GEMS technology accessible also to nonspecialist laboratories to facilitate the use of synthetic receptors in new research contexts.

Programmable protein expression using a genetically encoded m6A sensor

Illuminating mRNA modifications

An RNA Methylation-Sensitive AIEgen-Aptamer Reporting System for Quantitatively Evaluating M6a Methylase and Demethylase Activities

Targeted Manipulation of Cellular RNA m6A Methylation at theSingle-Base Level br

m<SUP>6</SUP>A-label-seq: A metabolic labeling protocol to detect transcriptome-wide mRNA N<SUP>6</SUP>-methyladenosine (m<SUP>6</SUP>A) at base resolution

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

A Programmable System to Methylate and Demethylate N6-methyladenosine (m6a) on Specific RNA Transcripts in Mammalian Cells

A Programmable System to Methylate and Demethylate M6a on Specific Mrnas

Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution

Sequencing-free Analysis of Multiple Methylations on Gene-Specific mRNAs

Construction of a Single-Molecule Biosensor for Antibody-Free Detection of Locus-Specific N6-Methyladenosine in Cancer Cells and Tissues.

Chemical Labelling for M6a Detection: Opportunities and Challenges.

Genetically encoded fluorescent sensor to monitor intracellular arginine methylation

Methylation-Powered Assembly of a Single Quantum Dot-Based FRET Nanosensor for Antibody-Free and Enzyme-Free Monitoring of Locus-Specific N6-Methyladenosine in Clinical Tissues.

Multiplexed In Situ Imaging of Site-Specific m6A Methylation with Proximity Hybridization Followed by Primer Exchange Amplification (m6A-PHPEA)

Identification of N-6-Methyladenosine Reader Proteins

A Demethylation-Switchable Aptamer Design Enables Lag-Free Monitoring of m 6 A Demethylase FTO with Energy Self-Sufficient and Structurally Integrated Features

Orthogonal Demethylase-Activated Deoxyribozyme for Intracellular Imaging and Gene Regulation.

Label-free and Sensitive Detection of N6-methyladenosine Demethylase Activity in Crude Cell Extracts and Clinical Cancer Tissues Based on Demethylation-Triggered Exponential Signal Amplification.

Programmable RNA N 6 -methyladenosine editing by CRISPR-Cas9 conjugates

Synthetic Receptors for Sensing Soluble Molecules with Mammalian Cells